1.
Eandi M, Ferrero L. Mesalazina: profilo farmacologico, terapeutico e farmacoeconomico. Farmeconomia. Health Economics and Therapeutic Pathways. 2003;4(4):201-216. https://doi.org/10.7175/fe.v4i4.780